| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 9.09e-11 | 26 | 57 | 6 | GO:0005248 | |
| GeneOntologyMolecularFunction | sodium channel activity | 7.59e-09 | 52 | 57 | 6 | GO:0005272 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | SCN11A CACNG1 SCN2A SCN4A SCN7A SCN8A SCN10A CHRNA2 CHRNB2 CHRNB3 | 4.14e-08 | 343 | 57 | 10 | GO:0005261 |
| GeneOntologyMolecularFunction | [heparan sulfate]-glucosamine N-sulfotransferase activity | 8.80e-08 | 4 | 57 | 3 | GO:0015016 | |
| GeneOntologyMolecularFunction | N-acetylglucosamine deacetylase activity | 8.80e-08 | 4 | 57 | 3 | GO:0050119 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 5.51e-07 | 171 | 57 | 7 | GO:0015081 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | SCN11A CACNG1 SCN2A SCN4A SCN7A SCN8A SCN10A CHRNA2 CHRNB2 CHRNB3 | 6.13e-07 | 459 | 57 | 10 | GO:0005216 |
| GeneOntologyMolecularFunction | channel activity | SCN11A CACNG1 SCN2A SCN4A SCN7A SCN8A SCN10A CHRNA2 CHRNB2 CHRNB3 | 2.06e-06 | 525 | 57 | 10 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | SCN11A CACNG1 SCN2A SCN4A SCN7A SCN8A SCN10A CHRNA2 CHRNB2 CHRNB3 | 2.10e-06 | 526 | 57 | 10 | GO:0022803 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SCN11A CACNG1 SCN2A SCN4A SCN7A SCN8A SCN10A CHRNA2 ATP4A CHRNB2 CHRNB3 | 2.32e-06 | 664 | 57 | 11 | GO:0008324 |
| GeneOntologyMolecularFunction | heparan sulfate sulfotransferase activity | 9.79e-06 | 15 | 57 | 3 | GO:0034483 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SCN11A CACNG1 SCN2A SCN4A SCN7A SCN8A SCN10A CHRNA2 ATP4A CHRNB2 CHRNB3 | 1.25e-05 | 793 | 57 | 11 | GO:0015075 |
| GeneOntologyMolecularFunction | acetylcholine-gated monoatomic cation-selective channel activity | 1.46e-05 | 17 | 57 | 3 | GO:0022848 | |
| GeneOntologyMolecularFunction | heparan sulfate N-deacetylase activity | 2.40e-05 | 3 | 57 | 2 | GO:0102140 | |
| GeneOntologyMolecularFunction | acetylcholine receptor activity | 3.75e-05 | 23 | 57 | 3 | GO:0015464 | |
| GeneOntologyMolecularFunction | gated channel activity | 4.44e-05 | 334 | 57 | 7 | GO:0022836 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 4.95e-05 | 465 | 57 | 8 | GO:0046873 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 5.47e-05 | 26 | 57 | 3 | GO:0031420 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides | 8.43e-05 | 81 | 57 | 4 | GO:0016811 | |
| GeneOntologyMolecularFunction | deacetylase activity | 2.02e-04 | 40 | 57 | 3 | GO:0019213 | |
| GeneOntologyMolecularFunction | excitatory extracellular ligand-gated monoatomic ion channel activity | 2.51e-04 | 43 | 57 | 3 | GO:0005231 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 3.84e-04 | 627 | 57 | 8 | GO:0022890 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SCN11A CACNG1 SCN2A SCN4A SCN7A SCN8A SCN10A CHRNA2 ATP4A CHRNB2 CHRNB3 | 4.38e-04 | 1180 | 57 | 11 | GO:0022857 |
| GeneOntologyMolecularFunction | sulfotransferase activity | 5.21e-04 | 55 | 57 | 3 | GO:0008146 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 5.78e-04 | 57 | 57 | 3 | GO:1904315 | |
| GeneOntologyMolecularFunction | acetylcholine binding | 6.12e-04 | 13 | 57 | 2 | GO:0042166 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 6.72e-04 | 60 | 57 | 3 | GO:0099529 | |
| GeneOntologyMolecularFunction | sodium ion binding | 7.13e-04 | 14 | 57 | 2 | GO:0031402 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds | 8.02e-04 | 146 | 57 | 4 | GO:0016810 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 8.50e-04 | 65 | 57 | 3 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 8.50e-04 | 65 | 57 | 3 | GO:0022824 | |
| GeneOntologyMolecularFunction | transporter activity | SCN11A CACNG1 SCN2A SCN4A SCN7A SCN8A SCN10A CHRNA2 ATP4A CHRNB2 CHRNB3 | 9.16e-04 | 1289 | 57 | 11 | GO:0005215 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 1.06e-03 | 17 | 57 | 2 | GO:0099508 | |
| GeneOntologyMolecularFunction | transferase activity, transferring sulphur-containing groups | 1.24e-03 | 74 | 57 | 3 | GO:0016782 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 1.29e-03 | 75 | 57 | 3 | GO:0098960 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 1.32e-03 | 758 | 57 | 8 | GO:0015318 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 1.39e-03 | 77 | 57 | 3 | GO:0005230 | |
| GeneOntologyMolecularFunction | transmembrane transporter binding | 1.47e-03 | 172 | 57 | 4 | GO:0044325 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 2.93e-03 | 100 | 57 | 3 | GO:0030594 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 7.49e-03 | 140 | 57 | 3 | GO:0099094 | |
| GeneOntologyMolecularFunction | quaternary ammonium group binding | 7.65e-03 | 46 | 57 | 2 | GO:0050997 | |
| GeneOntologyMolecularFunction | carboxylic ester hydrolase activity | 1.02e-02 | 157 | 57 | 3 | GO:0052689 | |
| GeneOntologyBiologicalProcess | neuronal action potential | 3.63e-10 | 63 | 56 | 7 | GO:0019228 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 1.25e-09 | 121 | 56 | 8 | GO:0051899 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 1.66e-08 | 62 | 56 | 6 | GO:0086002 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 2.14e-08 | 112 | 56 | 7 | GO:0019226 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 4.34e-08 | 36 | 56 | 5 | GO:0086010 | |
| GeneOntologyBiologicalProcess | action potential | 6.73e-08 | 201 | 56 | 8 | GO:0001508 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 1.30e-07 | 87 | 56 | 6 | GO:0086001 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 1.93e-07 | 93 | 56 | 6 | GO:0086003 | |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | 3.34e-07 | 167 | 56 | 7 | GO:0060048 | |
| GeneOntologyBiologicalProcess | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process | 1.05e-06 | 8 | 56 | 3 | GO:0015014 | |
| GeneOntologyBiologicalProcess | muscle contraction | 1.20e-06 | 400 | 56 | 9 | GO:0006936 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 1.22e-06 | 127 | 56 | 6 | GO:0070252 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 1.46e-06 | 208 | 56 | 7 | GO:0035725 | |
| GeneOntologyBiologicalProcess | behavioral response to pain | 1.66e-06 | 32 | 56 | 4 | GO:0048266 | |
| GeneOntologyBiologicalProcess | striated muscle contraction | 1.94e-06 | 217 | 56 | 7 | GO:0006941 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | SCN11A SCN2A SCN4A SCN7A SCN8A CNTNAP2 SCN10A CHRNA2 CHRNB2 CHRNB3 | 2.29e-06 | 559 | 56 | 10 | GO:0042391 |
| GeneOntologyBiologicalProcess | heparin biosynthetic process | 3.08e-06 | 11 | 56 | 3 | GO:0030210 | |
| GeneOntologyBiologicalProcess | sensory perception of mechanical stimulus | 3.57e-06 | 238 | 56 | 7 | GO:0050954 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 3.61e-06 | 153 | 56 | 6 | GO:0030048 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception of pain | 5.56e-06 | 43 | 56 | 4 | GO:0062149 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 9.21e-06 | 275 | 56 | 7 | GO:0006814 | |
| GeneOntologyBiologicalProcess | sensory perception of pain | 9.65e-06 | 105 | 56 | 5 | GO:0019233 | |
| GeneOntologyBiologicalProcess | response to pain | 1.11e-05 | 51 | 56 | 4 | GO:0048265 | |
| GeneOntologyBiologicalProcess | nerve development | 1.16e-05 | 109 | 56 | 5 | GO:0021675 | |
| GeneOntologyBiologicalProcess | response to abiotic stimulus | SCN11A PTPRK LOXL2 NTRK1 SCN2A SCN7A CNTNAP2 SCN10A GATA3 HMGCR EYA1 GRM8 CHRNB2 CPEB1 | 1.17e-05 | 1361 | 56 | 14 | GO:0009628 |
| GeneOntologyBiologicalProcess | heparin metabolic process | 1.25e-05 | 17 | 56 | 3 | GO:0030202 | |
| GeneOntologyBiologicalProcess | muscle system process | 1.52e-05 | 547 | 56 | 9 | GO:0003012 | |
| GeneOntologyBiologicalProcess | heart contraction | 1.55e-05 | 298 | 56 | 7 | GO:0060047 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus involved in sensory perception | 1.73e-05 | 57 | 56 | 4 | GO:0050974 | |
| GeneOntologyBiologicalProcess | response to nicotine | 1.85e-05 | 58 | 56 | 4 | GO:0035094 | |
| GeneOntologyBiologicalProcess | heart process | 1.96e-05 | 309 | 56 | 7 | GO:0003015 | |
| GeneOntologyBiologicalProcess | cranial nerve development | 3.29e-05 | 67 | 56 | 4 | GO:0021545 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | SCN11A CACNG1 SCN2A SCN4A SCN7A SCN8A SCN10A HRC CHRNA2 ATP4A CHRNB2 CHRNB3 | 3.59e-05 | 1115 | 56 | 12 | GO:0034220 |
| GeneOntologyBiologicalProcess | proteoglycan biosynthetic process | 3.91e-05 | 70 | 56 | 4 | GO:0030166 | |
| GeneOntologyBiologicalProcess | negative regulation of neuronal action potential | 4.33e-05 | 4 | 56 | 2 | GO:1904456 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus involved in sensory perception of pain | 4.72e-05 | 26 | 56 | 3 | GO:0050966 | |
| GeneOntologyBiologicalProcess | detection of temperature stimulus involved in sensory perception of pain | 4.72e-05 | 26 | 56 | 3 | GO:0050965 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus | 5.13e-05 | 75 | 56 | 4 | GO:0050982 | |
| GeneOntologyBiologicalProcess | glycosaminoglycan biosynthetic process | 5.41e-05 | 76 | 56 | 4 | GO:0006024 | |
| GeneOntologyBiologicalProcess | circadian rhythm | 5.58e-05 | 248 | 56 | 6 | GO:0007623 | |
| GeneOntologyBiologicalProcess | blood circulation | 5.71e-05 | 648 | 56 | 9 | GO:0008015 | |
| GeneOntologyBiologicalProcess | aminoglycan biosynthetic process | 6.61e-05 | 80 | 56 | 4 | GO:0006023 | |
| GeneOntologyBiologicalProcess | action potential initiation | 7.20e-05 | 5 | 56 | 2 | GO:0099610 | |
| GeneOntologyBiologicalProcess | behavioral response to chemical pain | 7.20e-05 | 5 | 56 | 2 | GO:0061366 | |
| GeneOntologyBiologicalProcess | behavioral response to formalin induced pain | 7.20e-05 | 5 | 56 | 2 | GO:0061368 | |
| GeneOntologyBiologicalProcess | detection of temperature stimulus involved in sensory perception | 7.31e-05 | 30 | 56 | 3 | GO:0050961 | |
| GeneOntologyBiologicalProcess | detection of temperature stimulus | 9.76e-05 | 33 | 56 | 3 | GO:0016048 | |
| GeneOntologyBiologicalProcess | heparan sulfate proteoglycan biosynthetic process | 1.17e-04 | 35 | 56 | 3 | GO:0015012 | |
| GeneOntologyBiologicalProcess | proteoglycan metabolic process | 1.40e-04 | 97 | 56 | 4 | GO:0006029 | |
| GeneOntologyBiologicalProcess | circulatory system process | 1.46e-04 | 733 | 56 | 9 | GO:0003013 | |
| GeneOntologyBiologicalProcess | sensory perception of temperature stimulus | 1.49e-04 | 38 | 56 | 3 | GO:0050951 | |
| GeneOntologyBiologicalProcess | mucopolysaccharide metabolic process | 1.57e-04 | 100 | 56 | 4 | GO:1903510 | |
| GeneOntologyBiologicalProcess | olfactory nerve development | 2.01e-04 | 8 | 56 | 2 | GO:0021553 | |
| GeneOntologyBiologicalProcess | synaptic transmission, cholinergic | 2.32e-04 | 44 | 56 | 3 | GO:0007271 | |
| GeneOntologyBiologicalProcess | negative regulation of transmission of nerve impulse | 2.57e-04 | 9 | 56 | 2 | GO:0051970 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | SCN11A CACNG1 SCN2A SCN4A SCN7A SCN8A SCN10A HRC CHRNA2 ATP4A CHRNB2 CHRNB3 | 2.62e-04 | 1374 | 56 | 12 | GO:0006811 |
| GeneOntologyBiologicalProcess | metal ion transport | SCN11A CACNG1 SCN2A SCN4A SCN7A SCN8A SCN10A HRC ATP4A CHRNB2 | 3.20e-04 | 1000 | 56 | 10 | GO:0030001 |
| GeneOntologyBiologicalProcess | negative regulation of action potential | 3.21e-04 | 10 | 56 | 2 | GO:0045759 | |
| GeneOntologyBiologicalProcess | cellular response to nicotine | 3.21e-04 | 10 | 56 | 2 | GO:0071316 | |
| GeneOntologyBiologicalProcess | glycosaminoglycan metabolic process | 3.27e-04 | 121 | 56 | 4 | GO:0030203 | |
| GeneOntologyBiologicalProcess | acetylcholine receptor signaling pathway | 3.60e-04 | 51 | 56 | 3 | GO:0095500 | |
| GeneOntologyBiologicalProcess | multicellular organismal response to stress | 3.81e-04 | 126 | 56 | 4 | GO:0033555 | |
| GeneOntologyBiologicalProcess | micturition | 3.92e-04 | 11 | 56 | 2 | GO:0060073 | |
| GeneOntologyBiologicalProcess | cellular response to acetylcholine | 4.03e-04 | 53 | 56 | 3 | GO:1905145 | |
| GeneOntologyBiologicalProcess | response to radiation | 4.06e-04 | 503 | 56 | 7 | GO:0009314 | |
| GeneOntologyBiologicalProcess | rhythmic process | 4.22e-04 | 360 | 56 | 6 | GO:0048511 | |
| GeneOntologyBiologicalProcess | excitatory postsynaptic potential | 4.29e-04 | 130 | 56 | 4 | GO:0060079 | |
| GeneOntologyBiologicalProcess | aminoglycan metabolic process | 4.55e-04 | 132 | 56 | 4 | GO:0006022 | |
| GeneOntologyBiologicalProcess | heparan sulfate proteoglycan biosynthetic process, enzymatic modification | 4.70e-04 | 12 | 56 | 2 | GO:0015015 | |
| GeneOntologyBiologicalProcess | response to acetylcholine | 4.75e-04 | 56 | 56 | 3 | GO:1905144 | |
| GeneOntologyBiologicalProcess | response to mechanical stimulus | 5.49e-04 | 247 | 56 | 5 | GO:0009612 | |
| GeneOntologyBiologicalProcess | chemical synaptic transmission, postsynaptic | 6.82e-04 | 147 | 56 | 4 | GO:0099565 | |
| GeneOntologyBiologicalProcess | regulation of neuronal action potential | 7.43e-04 | 15 | 56 | 2 | GO:0098908 | |
| GeneOntologyBiologicalProcess | regulation of system process | 7.76e-04 | 734 | 56 | 8 | GO:0044057 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | 7.83e-04 | 922 | 56 | 9 | GO:0098662 | |
| GeneOntologyBiologicalProcess | presynaptic modulation of chemical synaptic transmission | 8.03e-04 | 67 | 56 | 3 | GO:0099171 | |
| GeneOntologyBiologicalProcess | axonogenesis | 8.17e-04 | 566 | 56 | 7 | GO:0007409 | |
| GeneOntologyBiologicalProcess | postsynaptic signal transduction | 8.75e-04 | 69 | 56 | 3 | GO:0098926 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | 9.12e-04 | 942 | 56 | 9 | GO:0098655 | |
| GeneOntologyBiologicalProcess | otic vesicle development | 9.59e-04 | 17 | 56 | 2 | GO:0071599 | |
| GeneOntologyBiologicalProcess | response to light intensity | 9.59e-04 | 17 | 56 | 2 | GO:0009642 | |
| GeneOntologyBiologicalProcess | heparan sulfate proteoglycan metabolic process | 9.59e-04 | 17 | 56 | 2 | GO:0030201 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | SCN11A CACNG1 SCN2A SCN4A SCN7A SCN8A SCN10A HRC ATP4A CHRNB2 | 9.97e-04 | 1157 | 56 | 10 | GO:0006812 |
| GeneOntologyBiologicalProcess | polysaccharide biosynthetic process | 1.16e-03 | 76 | 56 | 3 | GO:0000271 | |
| GeneOntologyBiologicalProcess | synaptic signaling | 1.17e-03 | 976 | 56 | 9 | GO:0099536 | |
| GeneOntologyBiologicalProcess | detection of external stimulus | 1.25e-03 | 173 | 56 | 4 | GO:0009581 | |
| GeneOntologyBiologicalProcess | detection of abiotic stimulus | 1.30e-03 | 175 | 56 | 4 | GO:0009582 | |
| GeneOntologyBiologicalProcess | positive regulation of type 2 immune response | 1.33e-03 | 20 | 56 | 2 | GO:0002830 | |
| GeneOntologyBiologicalProcess | sulfur compound biosynthetic process | 1.39e-03 | 178 | 56 | 4 | GO:0044272 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane potential | 1.45e-03 | 180 | 56 | 4 | GO:0060078 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | 1.56e-03 | 1017 | 56 | 9 | GO:0098660 | |
| GeneOntologyBiologicalProcess | optic nerve development | 1.62e-03 | 22 | 56 | 2 | GO:0021554 | |
| GeneOntologyBiologicalProcess | axon development | 1.69e-03 | 642 | 56 | 7 | GO:0061564 | |
| GeneOntologyBiologicalProcess | sympathetic nervous system development | 1.92e-03 | 24 | 56 | 2 | GO:0048485 | |
| GeneOntologyBiologicalProcess | negative regulation of nervous system process | 1.92e-03 | 24 | 56 | 2 | GO:0031645 | |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | 2.03e-03 | 663 | 56 | 7 | GO:0050804 | |
| GeneOntologyBiologicalProcess | response to nitrogen compound | SCN11A CAD NTRK1 PRMT5 CNTNAP2 GRB14 CHRNA2 CHRNB2 CHRNB3 CPEB1 | 2.03e-03 | 1272 | 56 | 10 | GO:1901698 |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | 2.05e-03 | 664 | 56 | 7 | GO:0099177 | |
| GeneOntologyBiologicalProcess | cerebellar Purkinje cell layer morphogenesis | 2.09e-03 | 25 | 56 | 2 | GO:0021692 | |
| GeneOntologyBiologicalProcess | neuron projection development | SCN11A RNF6 PTPRK NTRK1 CNTNAP2 GATA3 HERC1 PLXNA1 CHRNB2 CPEB1 | 2.19e-03 | 1285 | 56 | 10 | GO:0031175 |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 3.79e-12 | 17 | 57 | 6 | GO:0001518 | |
| GeneOntologyCellularComponent | sodium channel complex | 1.42e-10 | 29 | 57 | 6 | GO:0034706 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | SCN11A CACNG1 SCN2A SCN4A SCN7A SCN8A CNTNAP2 SCN10A CHRNA2 CHRNB2 CHRNB3 | 5.12e-09 | 378 | 57 | 11 | GO:0034702 |
| GeneOntologyCellularComponent | transmembrane transporter complex | SCN11A CACNG1 SCN2A SCN4A SCN7A SCN8A CNTNAP2 SCN10A CHRNA2 ATP4A CHRNB2 CHRNB3 | 1.35e-08 | 523 | 57 | 12 | GO:1902495 |
| GeneOntologyCellularComponent | plasma membrane protein complex | SCN11A CACNG1 SCN2A SCN4A SCN7A SCN8A CNTNAP2 SCN10A CD74 SSPOP CHRNA2 ATP4A CHRNB2 CHRNB3 | 1.70e-08 | 785 | 57 | 14 | GO:0098797 |
| GeneOntologyCellularComponent | transporter complex | SCN11A CACNG1 SCN2A SCN4A SCN7A SCN8A CNTNAP2 SCN10A CHRNA2 ATP4A CHRNB2 CHRNB3 | 2.35e-08 | 550 | 57 | 12 | GO:1990351 |
| GeneOntologyCellularComponent | cation channel complex | 2.33e-07 | 235 | 57 | 8 | GO:0034703 | |
| GeneOntologyCellularComponent | axon | SCN11A CAD RNF6 PTPRK FSCN3 NTRK1 SCN2A SCN4A SCN8A CNTNAP2 SCN10A CPEB1 | 4.02e-06 | 891 | 57 | 12 | GO:0030424 |
| GeneOntologyCellularComponent | presynaptic membrane | 9.98e-06 | 277 | 57 | 7 | GO:0042734 | |
| GeneOntologyCellularComponent | neuronal cell body | SCN11A CAD DRP2 PTPRK PLXDC1 MYO10 NTRK1 SCN8A CNTNAP2 GRM8 CPEB1 | 1.33e-05 | 835 | 57 | 11 | GO:0043025 |
| GeneOntologyCellularComponent | acetylcholine-gated channel complex | 1.52e-05 | 18 | 57 | 3 | GO:0005892 | |
| GeneOntologyCellularComponent | synaptic membrane | 2.62e-05 | 583 | 57 | 9 | GO:0097060 | |
| GeneOntologyCellularComponent | cell body | SCN11A CAD DRP2 PTPRK PLXDC1 MYO10 NTRK1 SCN8A CNTNAP2 GRM8 CPEB1 | 3.56e-05 | 929 | 57 | 11 | GO:0044297 |
| GeneOntologyCellularComponent | membrane protein complex | SCN11A CACNG1 SCN2A SCN4A SCN7A SCN8A CNTNAP2 SCN10A CD74 SSPOP CHRNA2 ATP4A CHRNB2 CHRNB3 | 3.66e-05 | 1498 | 57 | 14 | GO:0098796 |
| GeneOntologyCellularComponent | C-fiber | 4.37e-05 | 4 | 57 | 2 | GO:0044299 | |
| GeneOntologyCellularComponent | axon initial segment | 6.68e-05 | 29 | 57 | 3 | GO:0043194 | |
| GeneOntologyCellularComponent | glutamatergic synapse | 3.40e-04 | 817 | 57 | 9 | GO:0098978 | |
| GeneOntologyCellularComponent | somatodendritic compartment | SCN11A CAD DRP2 PTPRK PLXDC1 MYO10 NTRK1 SCN8A CNTNAP2 GRM8 CPEB1 | 4.17e-04 | 1228 | 57 | 11 | GO:0036477 |
| GeneOntologyCellularComponent | presynapse | 6.12e-04 | 886 | 57 | 9 | GO:0098793 | |
| GeneOntologyCellularComponent | paranode region of axon | 9.68e-04 | 17 | 57 | 2 | GO:0033270 | |
| GeneOntologyCellularComponent | receptor complex | 9.80e-04 | 581 | 57 | 7 | GO:0043235 | |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 1.26e-03 | 78 | 57 | 3 | GO:0048787 | |
| GeneOntologyCellularComponent | node of Ranvier | 1.34e-03 | 20 | 57 | 2 | GO:0033268 | |
| GeneOntologyCellularComponent | dopaminergic synapse | 1.63e-03 | 22 | 57 | 2 | GO:0098691 | |
| GeneOntologyCellularComponent | main axon | 1.85e-03 | 89 | 57 | 3 | GO:0044304 | |
| GeneOntologyCellularComponent | methyltransferase complex | 3.20e-03 | 108 | 57 | 3 | GO:0034708 | |
| HumanPheno | EEG with focal spikes | 3.67e-06 | 26 | 22 | 4 | HP:0011193 | |
| HumanPheno | EEG with focal epileptiform discharges | 1.18e-04 | 118 | 22 | 5 | HP:0011185 | |
| HumanPheno | Neonatal electro-clinical non-motor seizure | 1.77e-04 | 5 | 22 | 2 | HP:0032812 | |
| HumanPheno | Neonatal seizure with electrographic correlate | 1.77e-04 | 5 | 22 | 2 | HP:0032808 | |
| HumanPheno | Neonatal electro-clinical seizure | 1.77e-04 | 5 | 22 | 2 | HP:0032809 | |
| HumanPheno | Neonatal electro-clinical seizure with behavior arrest | 1.77e-04 | 5 | 22 | 2 | HP:0032823 | |
| HumanPheno | Focal head nodding automatism seizure | 1.77e-04 | 5 | 22 | 2 | HP:0032906 | |
| HumanPheno | Allodynia | 1.77e-04 | 5 | 22 | 2 | HP:0012533 | |
| HumanPheno | Focal motor seizure | 1.93e-04 | 131 | 22 | 5 | HP:0011153 | |
| HumanPheno | Normal interictal EEG | 2.64e-04 | 6 | 22 | 2 | HP:0002372 | |
| HumanPheno | Eyelid myoclonia seizure | 3.69e-04 | 7 | 22 | 2 | HP:0032678 | |
| HumanPheno | Somnambulism | 3.69e-04 | 7 | 22 | 2 | HP:0025236 | |
| HumanPheno | Focal hyperkinetic seizure | 3.69e-04 | 7 | 22 | 2 | HP:0011174 | |
| HumanPheno | Long neck | 3.69e-04 | 7 | 22 | 2 | HP:0000472 | |
| MousePheno | decreased thermal nociceptive threshold | 2.63e-05 | 54 | 45 | 4 | MP:0003998 | |
| Domain | Na_channel_asu | 1.02e-13 | 10 | 55 | 6 | IPR001696 | |
| Domain | Na_trans_assoc | 1.02e-13 | 10 | 55 | 6 | IPR010526 | |
| Domain | Na_trans_assoc | 1.02e-13 | 10 | 55 | 6 | PF06512 | |
| Domain | IQ_motif_EF-hand-BS | 8.00e-09 | 90 | 55 | 7 | IPR000048 | |
| Domain | Channel_four-helix_dom | 1.59e-08 | 57 | 55 | 6 | IPR027359 | |
| Domain | - | 1.59e-08 | 57 | 55 | 6 | 1.20.120.350 | |
| Domain | HSNSD | 9.65e-08 | 4 | 55 | 3 | PF12062 | |
| Domain | Heparan_SO4_deacetylase | 9.65e-08 | 4 | 55 | 3 | IPR021930 | |
| Domain | IQ | 1.35e-07 | 81 | 55 | 6 | SM00015 | |
| Domain | IQ | 3.08e-07 | 93 | 55 | 6 | PS50096 | |
| Domain | Ion_trans_dom | 1.03e-06 | 114 | 55 | 6 | IPR005821 | |
| Domain | Ion_trans | 1.03e-06 | 114 | 55 | 6 | PF00520 | |
| Domain | Nicotinic_acetylcholine_rcpt | 1.32e-05 | 16 | 55 | 3 | IPR002394 | |
| Domain | - | 4.10e-05 | 23 | 55 | 3 | 1.20.120.370 | |
| Domain | Acetylcholine_rcpt_TM | 4.10e-05 | 23 | 55 | 3 | IPR027361 | |
| Domain | IQ | 5.65e-05 | 71 | 55 | 4 | PF00612 | |
| Domain | Na_trans_cytopl | 1.27e-04 | 6 | 55 | 2 | PF11933 | |
| Domain | Na_trans_cytopl | 1.27e-04 | 6 | 55 | 2 | IPR024583 | |
| Domain | Sulfotransferase_dom | 1.61e-04 | 36 | 55 | 3 | IPR000863 | |
| Domain | Sulfotransfer_1 | 1.61e-04 | 36 | 55 | 3 | PF00685 | |
| Domain | Neurotransmitter_ion_chnl_CS | 3.14e-04 | 45 | 55 | 3 | IPR018000 | |
| Domain | Neur_chan_memb | 3.35e-04 | 46 | 55 | 3 | PF02932 | |
| Domain | Neur_chan_LBD | 3.57e-04 | 47 | 55 | 3 | PF02931 | |
| Domain | NEUROTR_ION_CHANNEL | 3.57e-04 | 47 | 55 | 3 | PS00236 | |
| Domain | Neurotrans-gated_channel_TM | 3.57e-04 | 47 | 55 | 3 | IPR006029 | |
| Domain | - | 3.57e-04 | 47 | 55 | 3 | 2.70.170.10 | |
| Domain | Neur_channel | 3.57e-04 | 47 | 55 | 3 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 3.57e-04 | 47 | 55 | 3 | IPR006202 | |
| Domain | FA58C | 1.72e-03 | 21 | 55 | 2 | SM00231 | |
| Domain | FA58C_3 | 1.72e-03 | 21 | 55 | 2 | PS50022 | |
| Domain | FA58C_1 | 1.72e-03 | 21 | 55 | 2 | PS01285 | |
| Domain | FA58C_2 | 1.72e-03 | 21 | 55 | 2 | PS01286 | |
| Domain | F5_F8_type_C | 2.25e-03 | 24 | 55 | 2 | PF00754 | |
| Domain | FA58C | 2.25e-03 | 24 | 55 | 2 | IPR000421 | |
| Domain | Galactose-bd-like | 2.68e-03 | 94 | 55 | 3 | IPR008979 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 1.14e-09 | 31 | 51 | 6 | M877 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 1.40e-09 | 32 | 51 | 6 | M27455 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 3.69e-06 | 9 | 51 | 3 | M27597 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 3.69e-06 | 9 | 51 | 3 | MM15313 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 4.64e-06 | 121 | 51 | 6 | M872 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | 5.77e-06 | 367 | 51 | 9 | M48346 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 7.02e-06 | 130 | 51 | 6 | M27454 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HEPARAN_SULFATE_BIOSYNTHESIS | 7.21e-06 | 11 | 51 | 3 | M47921 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 7.21e-06 | 11 | 51 | 3 | M883 | |
| Pathway | REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 9.59e-06 | 12 | 51 | 3 | M48008 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 9.59e-06 | 12 | 51 | 3 | MM15312 | |
| Pathway | WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS | 1.39e-05 | 41 | 51 | 4 | M48095 | |
| Pathway | REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS | 1.58e-05 | 14 | 51 | 3 | M757 | |
| Pathway | REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS | 1.97e-05 | 15 | 51 | 3 | MM14704 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | SCN11A DRP2 MYO10 SCN2A SCN4A SCN7A SCN8A SCN10A HMGCR PLXNA1 | 3.32e-05 | 575 | 51 | 10 | M29853 |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 8.69e-05 | 203 | 51 | 6 | M5485 | |
| Pathway | KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE | 1.09e-04 | 26 | 51 | 3 | M7330 | |
| Pathway | REACTOME_HS_GAG_BIOSYNTHESIS | 1.53e-04 | 29 | 51 | 3 | MM14802 | |
| Pathway | REACTOME_HS_GAG_BIOSYNTHESIS | 1.87e-04 | 31 | 51 | 3 | M685 | |
| Pathway | REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM | 9.72e-04 | 54 | 51 | 3 | MM14633 | |
| Pathway | REACTOME_GLYCOSAMINOGLYCAN_METABOLISM | 1.00e-03 | 123 | 51 | 4 | MM14623 | |
| Pathway | REACTOME_GLYCOSAMINOGLYCAN_METABOLISM | 1.10e-03 | 126 | 51 | 4 | M695 | |
| Pathway | REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM | 1.14e-03 | 57 | 51 | 3 | M692 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | SCN11A DRP2 MYO10 SCN2A SCN4A SCN7A SCN8A SCN10A GATA3 HMGCR EYA1 CNOT3 PLXNA1 | 1.39e-03 | 1432 | 51 | 13 | M509 |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING | 1.69e-03 | 17 | 51 | 2 | M39686 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 1.89e-03 | 18 | 51 | 2 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 1.89e-03 | 18 | 51 | 2 | MM14882 | |
| Pathway | WP_GDNFRET_SIGNALING_AXIS | 2.83e-03 | 22 | 51 | 2 | MM15887 | |
| Pathway | WP_GDNFRET_SIGNALING_AXIS | 3.09e-03 | 23 | 51 | 2 | M39814 | |
| Pubmed | 1.36e-12 | 9 | 58 | 5 | 16382098 | ||
| Pubmed | 1.76e-08 | 4 | 58 | 3 | 22049073 | ||
| Pubmed | 1.76e-08 | 4 | 58 | 3 | 12070138 | ||
| Pubmed | 4.39e-08 | 5 | 58 | 3 | 17724025 | ||
| Pubmed | 4.39e-08 | 5 | 58 | 3 | 11087757 | ||
| Pubmed | 8.77e-08 | 6 | 58 | 3 | 16029194 | ||
| Pubmed | Are voltage-dependent ion channels involved in the endothelial cell control of vasomotor tone? | 8.77e-08 | 6 | 58 | 3 | 17513486 | |
| Pubmed | 8.77e-08 | 6 | 58 | 3 | 23711479 | ||
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 8.77e-08 | 6 | 58 | 3 | 23652591 | |
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 1.25e-07 | 139 | 58 | 6 | 16985003 | |
| Pubmed | Chromosomal localization of seven neuronal nicotinic acetylcholine receptor subunit genes in humans. | 1.53e-07 | 7 | 58 | 3 | 1505988 | |
| Pubmed | 1.53e-07 | 7 | 58 | 3 | 20231857 | ||
| Pubmed | 2.45e-07 | 8 | 58 | 3 | 17559419 | ||
| Pubmed | 2.45e-07 | 8 | 58 | 3 | 24067353 | ||
| Pubmed | 3.51e-07 | 35 | 58 | 4 | 18498732 | ||
| Pubmed | 3.67e-07 | 9 | 58 | 3 | 8906617 | ||
| Pubmed | 3.67e-07 | 9 | 58 | 3 | 15746173 | ||
| Pubmed | 3.67e-07 | 9 | 58 | 3 | 19228980 | ||
| Pubmed | 5.24e-07 | 10 | 58 | 3 | 20736995 | ||
| Pubmed | Developmental and regional expression of heparan sulfate sulfotransferase genes in the mouse brain. | 7.19e-07 | 11 | 58 | 3 | 15944372 | |
| Pubmed | 7.19e-07 | 11 | 58 | 3 | 12225896 | ||
| Pubmed | 9.58e-07 | 12 | 58 | 3 | 12460940 | ||
| Pubmed | 1.24e-06 | 13 | 58 | 3 | 15123669 | ||
| Pubmed | 1.58e-06 | 14 | 58 | 3 | 19059502 | ||
| Pubmed | 1.97e-06 | 15 | 58 | 3 | 33722956 | ||
| Pubmed | Analysis of nicotinic acetylcholine receptor subunits in the cochlea of the mouse. | 1.97e-06 | 15 | 58 | 3 | 8838678 | |
| Pubmed | 2.43e-06 | 16 | 58 | 3 | 19259974 | ||
| Pubmed | Heat-resistant action potentials require TTX-resistant sodium channels NaV1.8 and NaV1.9. | 2.73e-06 | 2 | 58 | 2 | 29970412 | |
| Pubmed | N-sulfation of heparan sulfate regulates early branching events in the developing mammary gland. | 2.73e-06 | 2 | 58 | 2 | 23060443 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 18399542 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 24144460 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 10758005 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 12634318 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 35348308 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 15760941 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 28450535 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 8144627 | ||
| Pubmed | Sodium channel expression within chronic multiple sclerosis plaques. | 2.73e-06 | 2 | 58 | 2 | 17805013 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 9565617 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 11144347 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 19931571 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 34930944 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 16857712 | ||
| Pubmed | Reconstitution of the human U snRNP assembly machinery reveals stepwise Sm protein organization. | 2.73e-06 | 2 | 58 | 2 | 26069323 | |
| Pubmed | The Nav1.9 channel is a key determinant of cold pain sensation and cold allodynia. | 2.73e-06 | 2 | 58 | 2 | 25959819 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 31534133 | ||
| Pubmed | Undersulfation of heparan sulfate restricts differentiation potential of mouse embryonic stem cells. | 2.73e-06 | 2 | 58 | 2 | 22298785 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 18601978 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 15319440 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 16984905 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 21287502 | ||
| Pubmed | FGF14 N-terminal splice variants differentially modulate Nav1.2 and Nav1.6-encoded sodium channels. | 2.73e-06 | 2 | 58 | 2 | 19465131 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 35365208 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 1846440 | ||
| Pubmed | Heparin/heparan sulfate biosynthesis: processive formation of N-sulfated domains. | 2.73e-06 | 2 | 58 | 2 | 18487608 | |
| Pubmed | Block of a subset of sodium channels exacerbates experimental autoimmune encephalomyelitis. | 2.73e-06 | 2 | 58 | 2 | 23735284 | |
| Pubmed | No evidence for association between 19 cholinergic genes and bipolar disorder. | 4.18e-06 | 19 | 58 | 3 | 17373692 | |
| Pubmed | Heparan sulfate biosynthetic gene Ndst1 is required for FGF signaling in early lens development. | 4.92e-06 | 20 | 58 | 3 | 17107998 | |
| Pubmed | 5.73e-06 | 21 | 58 | 3 | 25369838 | ||
| Pubmed | NDST1-dependent heparan sulfate regulates BMP signaling and internalization in lung development. | 6.63e-06 | 22 | 58 | 3 | 19299468 | |
| Pubmed | 7.61e-06 | 23 | 58 | 3 | 16446141 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 19058950 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 23640157 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 23943838 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 22345168 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 30395542 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 20923852 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 18991851 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 32845893 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 16033895 | ||
| Pubmed | Role of sodium channel subtype in action potential generation by neocortical pyramidal neurons. | 8.19e-06 | 3 | 58 | 2 | 29991598 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 9915799 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 28518218 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 38999942 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 25068303 | ||
| Pubmed | Conditional knockout of NaV1.6 in adult mice ameliorates neuropathic pain. | 8.19e-06 | 3 | 58 | 2 | 29497094 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 17928448 | ||
| Pubmed | Yield of peripheral sodium channels gene screening in pure small fibre neuropathy. | 8.19e-06 | 3 | 58 | 2 | 30554136 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 18479348 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 38514708 | ||
| Pubmed | CHRNA2 mutations are rare in the NFLE population: evaluation of a large cohort of Italian patients. | 8.19e-06 | 3 | 58 | 2 | 18226955 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 15302875 | ||
| Pubmed | Expression profile analysis of vulnerable CA1 pyramidal neurons in young-Middle-Aged Ts65Dn mice. | 1.27e-05 | 85 | 58 | 4 | 25131634 | |
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 27645992 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 17537961 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 35031483 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 29578003 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 10198179 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 21156207 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 29688404 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 19482438 | ||
| Pubmed | Heparan sulfate structure in mice with genetically modified heparan sulfate production. | 1.64e-05 | 4 | 58 | 2 | 15292174 | |
| Pubmed | Nedd4-2 haploinsufficiency causes hyperactivity and increased sensitivity to inflammatory stimuli. | 1.64e-05 | 4 | 58 | 2 | 27604420 | |
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 16056228 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 16314871 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 20854418 | ||
| Pubmed | 2.72e-05 | 5 | 58 | 2 | 24077057 | ||
| Pubmed | Early development of electrical excitability in the mouse enteric nervous system. | 2.72e-05 | 5 | 58 | 2 | 22875929 | |
| Pubmed | 2.72e-05 | 5 | 58 | 2 | 25031416 | ||
| Pubmed | 2.72e-05 | 5 | 58 | 2 | 9193799 | ||
| Interaction | PDGFRA interactions | 1.24e-06 | 385 | 57 | 9 | int:PDGFRA | |
| Interaction | C1orf54 interactions | 7.57e-06 | 167 | 57 | 6 | int:C1orf54 | |
| Interaction | SCN11A interactions | 9.53e-06 | 15 | 57 | 3 | int:SCN11A | |
| Interaction | IDS interactions | 2.25e-05 | 120 | 57 | 5 | int:IDS | |
| Interaction | CHRNA2 interactions | 2.35e-05 | 3 | 57 | 2 | int:CHRNA2 | |
| Interaction | SCN8A interactions | 2.36e-05 | 20 | 57 | 3 | int:SCN8A | |
| Interaction | SCGB2A2 interactions | 3.89e-05 | 223 | 57 | 6 | int:SCGB2A2 | |
| Interaction | CA6 interactions | 4.33e-05 | 69 | 57 | 4 | int:CA6 | |
| Interaction | SCN1A interactions | 7.44e-05 | 29 | 57 | 3 | int:SCN1A | |
| Interaction | BTNL2 interactions | 7.65e-05 | 155 | 57 | 5 | int:BTNL2 | |
| Interaction | PI15 interactions | 8.95e-05 | 83 | 57 | 4 | int:PI15 | |
| Interaction | NDST1 interactions | 1.21e-04 | 34 | 57 | 3 | int:NDST1 | |
| Cytoband | 3p22.2 | 4.25e-04 | 24 | 58 | 2 | 3p22.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q33 | 4.61e-04 | 118 | 58 | 3 | chr5q33 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q24 | 5.71e-04 | 127 | 58 | 3 | chr2q24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p21 | 6.82e-04 | 135 | 58 | 3 | chr8p21 | |
| Cytoband | 8p21.3 | 1.07e-03 | 38 | 58 | 2 | 8p21.3 | |
| Cytoband | 1p34.3 | 2.83e-03 | 62 | 58 | 2 | 1p34.3 | |
| Cytoband | 12q13 | 3.69e-03 | 71 | 58 | 2 | 12q13 | |
| Cytoband | 7q36.1 | 4.00e-03 | 74 | 58 | 2 | 7q36.1 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 7.49e-12 | 9 | 43 | 5 | 1203 | |
| GeneFamily | Cholinergic receptors nicotinic subunits | 6.87e-06 | 16 | 43 | 3 | 173 | |
| GeneFamily | Sulfotransferases, membrane bound | 9.20e-05 | 37 | 43 | 3 | 763 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.30e-06 | 163 | 58 | 5 | 132aece9c79499b4bb3c2bde68d3d7202e1d8772 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-Granular_Neuron_CB_Gabra6|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.39e-06 | 186 | 58 | 5 | d6c8ce2a32c218dcc63d861cc247152430ed3c8c | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.51e-06 | 187 | 58 | 5 | 7b2cd0c618ed081223343f3bec2244c8723c9a31 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.75e-06 | 189 | 58 | 5 | 975c0f079903ae36b0ffa54e86294d42ec7697de | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.75e-06 | 189 | 58 | 5 | 7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-06 | 192 | 58 | 5 | 5b7093d5af5ae7b0e6d3a464cc56272440ecedad | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-8|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 5.39e-06 | 194 | 58 | 5 | 55b97095a7a17a312c616703d291738a0f806339 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.66e-06 | 196 | 58 | 5 | 40e6900a0d56088a40d37ec312f53207ea952602 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.66e-06 | 196 | 58 | 5 | 0b247cf981981ae61aca5de82ef687e8d783c9ef | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.81e-06 | 197 | 58 | 5 | 983502a99e6d59bb36225b0246a9990604de1a01 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_B2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.58e-05 | 131 | 58 | 4 | 96d300958545714d18e905e860e95469c8ae4efa | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Tnc|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.85e-05 | 154 | 58 | 4 | 0066b2b8cfc74603e97f271ef5efc7ec512110dc | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Lypd1_Gpr88|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.23e-05 | 157 | 58 | 4 | 5aee90ad7aaa65fdabc23597451da5e48db8f4e6 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.05e-05 | 163 | 58 | 4 | 953a7db7e90a913e81002d2141fbbd5f1fdf2197 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibrocyte|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.34e-05 | 165 | 58 | 4 | 8a52f2dbcbd2bc1662b5e3fac381463fdcc3bf14 | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.64e-05 | 167 | 58 | 4 | e0f2509e86302eca8352821bce12597f6c51fc24 | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.64e-05 | 167 | 58 | 4 | b25646b6653cd8814dbeae4c74ce899ede105200 | |
| ToppCell | droplet-Thymus-nan-21m-Myeloid-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.80e-05 | 168 | 58 | 4 | 69dd747be46e7fbcec571cddd6dee374b9c2507a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.96e-05 | 169 | 58 | 4 | 0332f539a2f7d6dcd081a5d2f567290721f5a329 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.79e-05 | 174 | 58 | 4 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.96e-05 | 175 | 58 | 4 | 787ac1a12cda10af5c8830471702a4cbaf43e79e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.32e-05 | 177 | 58 | 4 | f35b04c3557ebbdeba37dec54c8f45880eafb422 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.51e-05 | 178 | 58 | 4 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.27e-05 | 182 | 58 | 4 | 5f513bbb7125956eb528e3120de3fd776770a7c3 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.27e-05 | 182 | 58 | 4 | fc4a5bf784705efe7965ce43ac23c2a8e602e90a | |
| ToppCell | Int-URO-Lymphocyte-B-B_naive|Int-URO / Disease, Lineage and Cell Type | 9.27e-05 | 182 | 58 | 4 | af7482c63e87a53cf686200a8f4d5b9749235dcd | |
| ToppCell | wk_08-11-Epithelial-PNS-PCP4+_neuron|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 9.67e-05 | 184 | 58 | 4 | eac2a9089913f33a961ba11519b53645790f2056 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.87e-05 | 185 | 58 | 4 | 70de48988c1f8e0809afc8092b663aa439d8e528 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.87e-05 | 185 | 58 | 4 | 08fad1e3c3cc5f1c3eb6629a49c094b628e75a92 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-04 | 187 | 58 | 4 | f124d2c699b717b7c02a1a70493f515b83dc2f4c | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.05e-04 | 188 | 58 | 4 | c2febf9fd4632af1f922067c3a30e5c50f75f480 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 189 | 58 | 4 | 09dd2b3d89416192e84abe302a6237b8f3fdcb6e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-04 | 189 | 58 | 4 | e32172ad09e93f6ac6ea2b92145b2b73003f7970 | |
| ToppCell | Globus_pallidus-Neuronal|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.09e-04 | 190 | 58 | 4 | 416de85d8841dac883faa6f5339b2fb461a09e82 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.09e-04 | 190 | 58 | 4 | 951e067d14412db67dc3babcdf61e41717d7b429 | |
| ToppCell | wk_08-11-Epithelial-PNS-SST+_neuron|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.12e-04 | 191 | 58 | 4 | df2bef74a54f4c23c99bd3b93225fd36bcd90723 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.14e-04 | 192 | 58 | 4 | ef86d82e4f04f9f54e821ef496d70fc81072d773 | |
| ToppCell | Posterior_cortex-Neuronal|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.16e-04 | 193 | 58 | 4 | b4989e3436e84dbec3789b46057e0f7a0ebf09d4 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-04 | 193 | 58 | 4 | 46d5d1f8150ebbc7f1941b96ab184491e5c1210b | |
| ToppCell | severe_influenza-B_naive|severe_influenza / disease group, cell group and cell class (v2) | 1.19e-04 | 194 | 58 | 4 | 7c1e9ce5de3bb1657a67010de673c8bb60129cb6 | |
| ToppCell | Hippocampus-Neuronal|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.19e-04 | 194 | 58 | 4 | 8aeb347b3024354c9505f4f0fddf0b843489dc6b | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.19e-04 | 194 | 58 | 4 | 36ce99b9e4e1c968cc7ae381168124cc7c14afb2 | |
| ToppCell | Influenza_Severe-B_naive|Influenza_Severe / Disease group and Cell class | 1.21e-04 | 195 | 58 | 4 | a25516ed670c7738670ffbaa6f7cd167946f3825 | |
| ToppCell | mild_COVID-19_(asymptomatic)-B_naive|World / disease group, cell group and cell class (v2) | 1.21e-04 | 195 | 58 | 4 | e763d9a431052c03cc6d514f2736506c6667e2be | |
| ToppCell | severe_COVID-19-B_naive|World / disease group, cell group and cell class (v2) | 1.21e-04 | 195 | 58 | 4 | e6c77119494b787c44502c0390fb2c86a34b1846 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma-muscle|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.21e-04 | 195 | 58 | 4 | 80b973d2a23ef9b101c90e1635e68c9a3f78f65d | |
| ToppCell | mild_COVID-19_(asymptomatic)-B_naive|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 1.23e-04 | 196 | 58 | 4 | c87499aa570f8fab878c4c015e47c711a3a21e9c | |
| ToppCell | mild_COVID-19-B_naive|mild_COVID-19 / disease group, cell group and cell class (v2) | 1.23e-04 | 196 | 58 | 4 | 00398079d3ac14dc2026c0cbd7388f1f3257b134 | |
| ToppCell | Healthy/Control-B_naive|Healthy/Control / Disease group and Cell class | 1.23e-04 | 196 | 58 | 4 | e92d2c814d2dcb049f3e455fe66fd40898b3524d | |
| ToppCell | Healthy_donor-B_naive|Healthy_donor / disease group, cell group and cell class (v2) | 1.23e-04 | 196 | 58 | 4 | cf254b1466357984201595fa32408d659eb741ef | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.23e-04 | 196 | 58 | 4 | 7acd782a587b7d331517f60daa8b5c2177bedfc7 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-04 | 196 | 58 | 4 | f40d10ea7714067585493fdc89744714aa427de8 | |
| ToppCell | Healthy/Control-B_naive|World / Disease group and Cell class | 1.23e-04 | 196 | 58 | 4 | ec935a4e16495c87b17070eb13c1e28bdb64e7ee | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.23e-04 | 196 | 58 | 4 | 73f029d2b276776d6c24356b14c6592c9cb74bd5 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-04 | 196 | 58 | 4 | b8350340d86e4524e9616a427e7f2e116a6fb3be | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.26e-04 | 197 | 58 | 4 | 12370ee857fddf1cf26196b23c21b68dcea48eb3 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.26e-04 | 197 | 58 | 4 | af819b0561c8db582c5b466d804153d69d3297e0 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.26e-04 | 197 | 58 | 4 | 4a04da876a1482604452ae53c124ae68eda0bd5e | |
| ToppCell | mild_COVID-19-B_naive|World / disease group, cell group and cell class (v2) | 1.26e-04 | 197 | 58 | 4 | b817ecdcea453a15fd0dd1d7fdf196bed68f7358 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.26e-04 | 197 | 58 | 4 | 2872a78b1be61aa1d50bc9a49294a21e922dc033 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.28e-04 | 198 | 58 | 4 | eb78b2ae6a787dbc75947e8dd5a03693285bc8be | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.28e-04 | 198 | 58 | 4 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-B-B_naive|COVID-19_Mild / Disease, condition lineage and cell class | 1.33e-04 | 200 | 58 | 4 | e6a43eff47195e1d39530ad49ad908fc06a8b038 | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-B-B_naive|Int-URO / Disease, condition lineage and cell class | 1.33e-04 | 200 | 58 | 4 | d2bf9792503fbe84f1dcac8c8ca02b504a07ab45 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 1.33e-04 | 200 | 58 | 4 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-B-B_naive|Influenza_Severe / Disease, condition lineage and cell class | 1.33e-04 | 200 | 58 | 4 | 0e05600d725dc5cc9afccc11eedc60efa41e4e46 | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-B|Influenza_Severe / Disease, condition lineage and cell class | 1.33e-04 | 200 | 58 | 4 | bf238a0a074d6c5cba8cb73d3b715ee701a612b6 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.33e-04 | 200 | 58 | 4 | 13ec8afea86e4a10599c924871ba4e325b0a8013 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Rln3_(parabrachial_pigmented_nucleus_(PBP))-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.06e-04 | 88 | 58 | 3 | b4620e79ea80681305434707e87cb02a7c6a5e4f | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Rln3_(parabrachial_pigmented_nucleus_(PBP))--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.06e-04 | 88 | 58 | 3 | 7992f8e621edf464bffcb70a6cc5f3b60c1d96f8 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Rln3_(parabrachial_pigmented_nucleus_(PBP))|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.06e-04 | 88 | 58 | 3 | b7b55f51af8ffa82813a4747580985a430da9ed1 | |
| Computational | Genes in the cancer module 267. | 2.11e-05 | 15 | 40 | 3 | MODULE_267 | |
| Computational | Ion channels. | 1.31e-04 | 27 | 40 | 3 | MODULE_214 | |
| Computational | Genes in the cancer module 201. | 8.29e-04 | 50 | 40 | 3 | MODULE_201 | |
| Computational | Genes in the cancer module 175. | 1.04e-03 | 54 | 40 | 3 | MODULE_175 | |
| Computational | Porins / transporters. | 1.05e-03 | 211 | 40 | 5 | MODULE_63 | |
| Computational | AcetylCholine receptors. | 1.19e-03 | 14 | 40 | 2 | MODULE_328 | |
| Drug | APETx1, Anthopleura elegantissima | 5.27e-10 | 6 | 57 | 4 | ctd:C475726 | |
| Drug | bupropion | 1.27e-09 | 81 | 57 | 7 | CID000000444 | |
| Drug | pilsicainide | 1.63e-09 | 46 | 57 | 6 | CID000004820 | |
| Drug | disopyramide | 1.52e-08 | 66 | 57 | 6 | CID000003114 | |
| Drug | strychnine HCl | 1.62e-08 | 181 | 57 | 8 | CID000005304 | |
| Drug | NSC7524 | 1.69e-08 | 182 | 57 | 8 | CID000005657 | |
| Drug | benzocaine | 3.37e-08 | 37 | 57 | 5 | CID000002337 | |
| Drug | APETx2 protein, Anthopleura elegantissima | 5.94e-08 | 4 | 57 | 3 | ctd:C501880 | |
| Drug | Nicorette | BMP1 LOXL2 NTRK1 SCN4A SCN7A SCN10A HMGCR GRM8 CHRNA2 CHRNB2 CHRNB3 | 6.74e-08 | 529 | 57 | 11 | CID000000942 |
| Drug | tetradotoxin | SCN11A SCN2A SCN4A SCN7A SCN8A SCN10A GRM8 CHRNA2 CHRNB2 CHRNB3 | 9.74e-08 | 428 | 57 | 10 | CID000020382 |
| Drug | procaine | 1.08e-07 | 153 | 57 | 7 | CID000004914 | |
| Drug | lamotrigine | 4.51e-07 | 116 | 57 | 6 | CID000003878 | |
| Drug | procainamide | 4.69e-07 | 190 | 57 | 7 | CID000004913 | |
| Drug | Oxamniquine [21738-42-1]; Up 200; 14.4uM; MCF7; HT_HG-U133A | 5.59e-07 | 195 | 57 | 7 | 4124_UP | |
| Drug | 2,3,5,6-tetrafluoro-4-methylbenzyl (Z)-(1RS)-cis-3-(2-chloro-3,3,3-trifluoroprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate | 8.26e-07 | 8 | 57 | 3 | ctd:C489827 | |
| Drug | 1,2-dichlorohexafluorocyclobutane | 2.19e-06 | 37 | 57 | 4 | CID000009643 | |
| Drug | memantine | 2.45e-06 | 86 | 57 | 5 | CID000004054 | |
| Drug | pyridostigmine | 3.61e-06 | 93 | 57 | 5 | CID000004991 | |
| Drug | QX-222 | 3.68e-06 | 42 | 57 | 4 | CID000005014 | |
| Drug | ketamine | 3.99e-06 | 262 | 57 | 7 | CID000003821 | |
| Drug | potassium | CACNG1 SCN2A SCN4A SCN7A CNTNAP2 SCN10A HMGCR GRM8 CHRNA2 ATP4A CHRNB2 CHRNB3 | 5.94e-06 | 1008 | 57 | 12 | CID000000813 |
| Drug | isoflurane | 6.03e-06 | 279 | 57 | 7 | CID000003763 | |
| Drug | mu-conotoxin KIIIA, Conus kinoshitai | 6.16e-06 | 2 | 57 | 2 | ctd:C502265 | |
| Drug | (-)-pictamine | 6.63e-06 | 15 | 57 | 3 | CID006918623 | |
| Drug | (-)-lepadin B | 6.63e-06 | 15 | 57 | 3 | CID006918624 | |
| Drug | UB-165 | 6.63e-06 | 15 | 57 | 3 | CID004694339 | |
| Drug | indoxacarb | 6.88e-06 | 49 | 57 | 4 | CID000107720 | |
| Drug | midazolam | 7.19e-06 | 107 | 57 | 5 | CID000004192 | |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A | 7.48e-06 | 188 | 57 | 6 | 5596_UP | |
| Drug | 1-phenylethanol | 8.08e-06 | 51 | 57 | 4 | CID000007409 | |
| Drug | AC1L2SVN | 8.14e-06 | 16 | 57 | 3 | CID000127922 | |
| Drug | propofol | 8.19e-06 | 191 | 57 | 6 | CID000004943 | |
| Drug | Finasteride [98319-26-7]; Up 200; 10.8uM; PC3; HT_HG-U133A | 9.77e-06 | 197 | 57 | 6 | 3744_UP | |
| Drug | Heliotrine [303-33-3]; Up 200; 12.8uM; PC3; HT_HG-U133A | 9.77e-06 | 197 | 57 | 6 | 3717_UP | |
| Drug | Zonisamide | 9.87e-06 | 17 | 57 | 3 | DB00909 | |
| Drug | Oxalamine citrate salt [1949-20-8]; Down 200; 9.2uM; PC3; HT_HG-U133A | 1.04e-05 | 199 | 57 | 6 | 6624_DN | |
| Drug | pseudococaine | 1.12e-05 | 570 | 57 | 9 | CID000002826 | |
| Drug | ABT-594 | 1.18e-05 | 18 | 57 | 3 | CID003075702 | |
| Drug | AC1LCVGE | 1.18e-05 | 18 | 57 | 3 | CID000656712 | |
| Drug | AC1L9P88 | 1.40e-05 | 19 | 57 | 3 | CID000450860 | |
| Drug | isoarecolone | 1.40e-05 | 19 | 57 | 3 | CID000146970 | |
| Drug | beta-erythroidine | 1.40e-05 | 19 | 57 | 3 | CID000010074 | |
| Drug | perhydrohistrionicotoxin | 1.40e-05 | 19 | 57 | 3 | CID000107881 | |
| Drug | diprafenone | 1.40e-05 | 19 | 57 | 3 | CID000071249 | |
| Drug | 4-(N-maleimido)benzyltrimethylammonium | 1.40e-05 | 19 | 57 | 3 | CID000162425 | |
| Drug | 3-(2-azetidinylmethoxy)pyridine | 1.65e-05 | 20 | 57 | 3 | CID000001962 | |
| Drug | quindine | 1.78e-05 | 219 | 57 | 6 | CID000001065 | |
| Drug | phenytoin | 1.78e-05 | 219 | 57 | 6 | CID000001775 | |
| Drug | sazetidine-A | 1.84e-05 | 3 | 57 | 2 | ctd:C514816 | |
| Drug | dinotefuran | 1.92e-05 | 21 | 57 | 3 | CID000197701 | |
| Drug | meproadifen | 1.92e-05 | 21 | 57 | 3 | CID000189752 | |
| Drug | pentobarbital | 2.02e-05 | 224 | 57 | 6 | CID000004737 | |
| Drug | saxitoxin | 2.13e-05 | 65 | 57 | 4 | CID000037165 | |
| Drug | AR-R17779 | 2.21e-05 | 22 | 57 | 3 | CID005310971 | |
| Drug | histrionicotoxin | 2.21e-05 | 22 | 57 | 3 | CID005282247 | |
| Drug | clothianidin | 2.21e-05 | 22 | 57 | 3 | CID000213027 | |
| Drug | AC1L3BL8 | 2.54e-05 | 23 | 57 | 3 | CID000086457 | |
| Drug | alpha-conotoxin ImI | 2.54e-05 | 23 | 57 | 3 | CID000133011 | |
| Drug | CID6325740 | 2.54e-05 | 23 | 57 | 3 | CID006325740 | |
| Drug | ABT-418 | 2.54e-05 | 23 | 57 | 3 | CID000119380 | |
| Drug | alpha-conotoxin SI | 2.54e-05 | 23 | 57 | 3 | CID000163979 | |
| Drug | Skpymrfamide | 2.54e-05 | 23 | 57 | 3 | CID000132661 | |
| Drug | GBR 12909 | 2.70e-05 | 69 | 57 | 4 | CID000003455 | |
| Drug | procyclidine | 2.90e-05 | 24 | 57 | 3 | CID000004919 | |
| Drug | intruder | 2.90e-05 | 24 | 57 | 3 | CID000213021 | |
| Drug | anabaseine | 2.90e-05 | 24 | 57 | 3 | CID000018985 | |
| Drug | T2755 | 3.03e-05 | 71 | 57 | 4 | CID000005514 | |
| Drug | flecainide | 3.03e-05 | 71 | 57 | 4 | CID000003355 | |
| Drug | anabasine | 3.29e-05 | 25 | 57 | 3 | CID000002181 | |
| Drug | varenicline | 3.29e-05 | 25 | 57 | 3 | CID000170361 | |
| Drug | pempidine | 3.29e-05 | 25 | 57 | 3 | CID000006603 | |
| Drug | AC1NT1AF | 3.29e-05 | 25 | 57 | 3 | CID005322157 | |
| Drug | Fospropofol | 3.68e-05 | 4 | 57 | 2 | DB06716 | |
| Drug | beta-erythroidine | 3.68e-05 | 4 | 57 | 2 | ctd:C004873 | |
| Drug | Propofol | 3.68e-05 | 4 | 57 | 2 | DB00818 | |
| Drug | benzquinamide | 3.71e-05 | 26 | 57 | 3 | CID000002342 | |
| Drug | Pirmenolum | 3.71e-05 | 26 | 57 | 3 | CID000004853 | |
| Drug | beta-eudesmol | 3.71e-05 | 26 | 57 | 3 | CID000091457 | |
| Drug | curarine | 3.71e-05 | 26 | 57 | 3 | CID000198004 | |
| Drug | PbTx-1 | 4.17e-05 | 27 | 57 | 3 | CID006437089 | |
| Drug | methylcarbamylcholine | 4.17e-05 | 27 | 57 | 3 | CID000004136 | |
| Drug | nornicotine | 4.17e-05 | 27 | 57 | 3 | CID000000412 | |
| Drug | AC1L1MOZ | 4.17e-05 | 27 | 57 | 3 | CID000031958 | |
| Drug | nefopam | 4.17e-05 | 27 | 57 | 3 | CID000004450 | |
| Drug | paraben | 4.66e-05 | 28 | 57 | 3 | CID000007175 | |
| Drug | bromoacetylcholine bromide | 5.19e-05 | 29 | 57 | 3 | CID000204966 | |
| Drug | MPTP-HCl | 5.32e-05 | 162 | 57 | 5 | CID000001388 | |
| Drug | tocainide | 5.76e-05 | 30 | 57 | 3 | CID000038945 | |
| Drug | Sodium | 5.87e-05 | 84 | 57 | 4 | ctd:D012964 | |
| Drug | Procaine | 6.13e-05 | 5 | 57 | 2 | DB00721 | |
| Drug | AC1L1JK6 | 6.36e-05 | 31 | 57 | 3 | CID000005077 | |
| Drug | gabapentin | 6.51e-05 | 169 | 57 | 5 | CID000003446 | |
| Drug | neostigmine | 6.73e-05 | 87 | 57 | 4 | CID000004456 | |
| Drug | tropicamide | 7.01e-05 | 32 | 57 | 3 | CID000005593 | |
| Drug | NSC93767 | 7.01e-05 | 32 | 57 | 3 | CID000005658 | |
| Drug | tetracaine | 7.04e-05 | 88 | 57 | 4 | CID000005411 | |
| Drug | mecamylamine | 7.36e-05 | 89 | 57 | 4 | CID000004032 | |
| Drug | riluzole | 7.47e-05 | 174 | 57 | 5 | CID000005070 | |
| Drug | toluene | 7.68e-05 | 175 | 57 | 5 | CID000001140 | |
| Drug | DB08666 | 7.68e-05 | 90 | 57 | 4 | CID011840988 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 9.22e-15 | 10 | 58 | 6 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 9.22e-15 | 10 | 58 | 6 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 4.05e-14 | 12 | 58 | 6 | DOID:0060170 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 1.11e-09 | 163 | 58 | 8 | DOID:1826 (implicated_via_orthology) | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.02e-08 | 152 | 58 | 7 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Hereditary Sensory Autonomic Neuropathy, Type 5 | 2.51e-07 | 7 | 58 | 3 | C0020075 | |
| Disease | Congenital Pain Insensitivity | 2.51e-07 | 7 | 58 | 3 | C0002768 | |
| Disease | congenital myasthenic syndrome (implicated_via_orthology) | 3.96e-06 | 16 | 58 | 3 | DOID:3635 (implicated_via_orthology) | |
| Disease | Benign familial infantile epilepsy | 1.14e-05 | 3 | 58 | 2 | cv:C5575231 | |
| Disease | PAROXYSMAL EXTREME PAIN DISORDER | 1.14e-05 | 3 | 58 | 2 | C1833661 | |
| Disease | Primary Erythermalgia | 1.14e-05 | 3 | 58 | 2 | C0014805 | |
| Disease | intellectual disability (implicated_via_orthology) | 1.47e-05 | 75 | 58 | 4 | DOID:1059 (implicated_via_orthology) | |
| Disease | azoospermia (implicated_via_orthology) | 2.04e-05 | 27 | 58 | 3 | DOID:14227 (implicated_via_orthology) | |
| Disease | Autosomal dominant nocturnal frontal lobe epilepsy | 2.27e-05 | 4 | 58 | 2 | cv:C3696898 | |
| Disease | hereditary sensory neuropathy (implicated_via_orthology) | 3.78e-05 | 5 | 58 | 2 | DOID:0050548 (implicated_via_orthology) | |
| Disease | Familial benign neonatal epilepsy | 5.67e-05 | 6 | 58 | 2 | C0220669 | |
| Disease | Autosomal Dominant Nocturnal Frontal Lobe Epilepsy | 7.92e-05 | 7 | 58 | 2 | C3696898 | |
| Disease | asthma (biomarker_via_orthology) | 2.17e-04 | 59 | 58 | 3 | DOID:2841 (biomarker_via_orthology) | |
| Disease | nodular sclerosis Hodgkin lymphoma | 3.40e-04 | 14 | 58 | 2 | EFO_0004708 | |
| Disease | Bipolar Disorder | 3.44e-04 | 477 | 58 | 6 | C0005586 | |
| Disease | Neuralgia, Supraorbital | 4.48e-04 | 16 | 58 | 2 | C0038870 | |
| Disease | Neuralgia, Iliohypogastric Nerve | 4.48e-04 | 16 | 58 | 2 | C0423712 | |
| Disease | Neuralgia, Perineal | 4.48e-04 | 16 | 58 | 2 | C0423711 | |
| Disease | Neuralgia | 4.48e-04 | 16 | 58 | 2 | C0027796 | |
| Disease | idiopathic scoliosis (implicated_via_orthology) | 4.48e-04 | 16 | 58 | 2 | DOID:0060250 (implicated_via_orthology) | |
| Disease | Neuralgia, Atypical | 4.48e-04 | 16 | 58 | 2 | C0234247 | |
| Disease | Neuralgia, Stump | 4.48e-04 | 16 | 58 | 2 | C0234249 | |
| Disease | Paroxysmal Nerve Pain | 4.48e-04 | 16 | 58 | 2 | C0751373 | |
| Disease | Nerve Pain | 4.48e-04 | 16 | 58 | 2 | C0751372 | |
| Disease | Neuralgia, Ilioinguinal | 4.48e-04 | 16 | 58 | 2 | C0751371 | |
| Disease | Neuralgia, Vidian | 4.48e-04 | 16 | 58 | 2 | C0042656 | |
| Disease | schizophrenia (is_implicated_in) | 4.94e-04 | 78 | 58 | 3 | DOID:5419 (is_implicated_in) | |
| Disease | Febrile seizure (within the age range of 3 months to 6 years) | 5.69e-04 | 18 | 58 | 2 | HP_0002373 | |
| Disease | Epilepsy, Cryptogenic | 5.72e-04 | 82 | 58 | 3 | C0086237 | |
| Disease | Awakening Epilepsy | 5.72e-04 | 82 | 58 | 3 | C0751111 | |
| Disease | Aura | 5.72e-04 | 82 | 58 | 3 | C0236018 | |
| Disease | Neurodevelopmental Disorders | 8.25e-04 | 93 | 58 | 3 | C1535926 | |
| Disease | Attention Deficit Disorder | 8.55e-04 | 22 | 58 | 2 | C0041671 | |
| Disease | Minimal Brain Dysfunction | 8.55e-04 | 22 | 58 | 2 | C1321905 | |
| Disease | Attention deficit hyperactivity disorder | 1.02e-03 | 24 | 58 | 2 | C1263846 | |
| Disease | Epilepsy | 1.31e-03 | 109 | 58 | 3 | C0014544 | |
| Disease | Autistic Disorder | 1.74e-03 | 261 | 58 | 4 | C0004352 | |
| Disease | social communication impairment | 1.81e-03 | 32 | 58 | 2 | EFO_0005427 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DHSMWFHAPFRADHW | 256 | O14734 | |
| HHRSSSTYHPMAPWV | 321 | Q05901 | |
| NVHHRSPSTHTMPHW | 351 | Q15822 | |
| GHIFIWDRHTAEHLM | 741 | Q58WW2 | |
| FWHEHTRPDRDRHVS | 221 | P13497 | |
| HWAVLSPHMEHHNTT | 31 | Q06432 | |
| AMEEAAWHHMPHPSD | 616 | O75175 | |
| AWHHMPHPSDSERIR | 621 | O75175 | |
| DAAHAAWTHMRGFPL | 501 | Q96T37 | |
| TGWEEHTFDNMLHLH | 966 | Q6ZRR7 | |
| HTAVEMHHWCIPFSV | 291 | P04629 | |
| TDDFWCHMHSPLIHH | 326 | Q05BQ5 | |
| FRMHGLFVASHPWEV | 6 | P04035 | |
| PVHDFNHRTTSDMWL | 2096 | Q15751 | |
| IWHDCHRHYHSMEVF | 621 | Q9Y4K0 | |
| HHCAADTPASWMHAR | 841 | Q9UIW2 | |
| FWRISSHSDLMALHH | 571 | Q99502 | |
| VLHCNADTPEEMHHW | 1361 | Q9HD67 | |
| WFPHMWSHMQPHLFH | 386 | P52848 | |
| WFPHMWSHMQPHLFH | 376 | Q9H3R1 | |
| WSHMQPHLFHNESSL | 381 | Q9H3R1 | |
| DMQWAHREHTHPASV | 501 | O00222 | |
| MEVTADQPRWVSHHH | 1 | P23771 | |
| APHTLIRQHMDHRHW | 2536 | Q9UFH2 | |
| EWRDSMPDWHHHCQV | 356 | Q9H9V9 | |
| SAYHMWTPRPALHVH | 131 | Q9NQT6 | |
| HIHTGHHSSMFWMRV | 141 | O14744 | |
| HYIHWDHVMVPHWDP | 121 | Q5VSG8 | |
| MAIHRSQPWFHHKIS | 431 | Q14449 | |
| MTGSLLDDHHWHSVV | 266 | Q9UHC6 | |
| WHWRHSMEGLRHHSP | 541 | Q9BZB8 | |
| HHWLLFEMSRHSLEQ | 186 | P04233 | |
| RMTVSHLWFDNHIHT | 396 | P20648 | |
| MWPHADTHSRIEHFA | 711 | Q13474 | |
| WNSTHHVFMHLHPGT | 551 | Q15262 | |
| DCNLPRWHMHDFFHS | 736 | P35499 | |
| ARFVRVWPHDVHHSD | 2201 | A2VEC9 | |
| WAVRFMLRHHLTPHA | 1071 | Q7Z3K3 | |
| MHEFHIHCIDRWLSE | 651 | Q9Y252 | |
| MGHHRPWLHASVLWA | 1 | P23327 | |
| VHHRSPTTHTMAPWV | 321 | P17787 | |
| PAWLMSETLRHLHTH | 156 | Q9P2E5 | |
| RRRMFWETSPDSHHH | 196 | Q6P3X8 | |
| MSFEAHHLTVPAIRW | 296 | Q9Y5K1 | |
| SAPHEDWPRWHMHDF | 821 | Q9Y5Y9 | |
| DWPRWHMHDFFHSFL | 826 | Q9Y5Y9 | |
| WHHEHGSQPELSYLM | 586 | Q8TEQ6 | |
| NDCELPRWHMHDFFH | 916 | Q99250 | |
| PRWHMHDFFHSFLIV | 921 | Q99250 | |
| FFWPSLLHMHERTHT | 206 | Q96GE5 | |
| FPHMWSHMQPHLFHN | 386 | P52849 | |
| DCELPRWHMHDFFHS | 911 | Q9UQD0 | |
| DHLHLRWTTEQHMPE | 6 | B1AK76 | |
| HEWTIPSHMPFSKAH | 1756 | P27708 | |
| AFAWLSHLMEHHSSH | 421 | Q8TBC5 | |
| FFWPSLLHMHERTHT | 206 | Q9Y2A4 | |
| LPRWHMHDFFHSFLN | 666 | Q01118 | |
| LRHWHMGDFWHSFLV | 746 | Q9UI33 | |
| AFQRHFAEWRHAHGM | 421 | Q12874 | |
| SHWREHMYIHTGKPF | 376 | Q8N680 | |
| HWPAMKFRSHPDHST | 466 | Q8IUK5 | |
| LELHDWMCTHFEEHP | 201 | Q9UBP6 |